1Department of Dermatology, Alcalá la Real High Resolution Hospital, Jaén, Spain; 2Department of Dermatology, University Hospital Complex of Granada, Granada, Spain *Corresponding Author e-mail: gonzaloblascomorente@gmail.com فحص تألقي بلون أمحر مرجاين لرتسبات الوذح اجللدي غونزالو بال�صكو-مورينتى، �صلفادور اأريا�ض-�صانتياغو، اإ�رضائيل برييز-لوبيز، اأنطونيو مارتينيز-لوبيز Coral-Red Fluorescence of Erythrasma Plaque *Gonzalo Blasco-Morente,1 Salvador Arias-Santiago,2 Israel Pérez-López,2 Antonio Martínez-López2 A 50-year-old man presented to the Department of Dermatology, University Hospital Complex of Granada, Granada, Spain, in 2015 with a slightly pruritic rash on the left groin, which he had had for two years. He had attended the hospital previously and been diagnosed with eczema and tinea cruris. This had been treated with topical steroids and antifungal drugs (methylprednisolone and sertaconazole) for several months without improvement. A physical examination of the patient showed a diffuse, brownish, well-defined, scaly plaque in the left inguinal region [Figure 1A]. A potassium hydroxide preparation of tissue scrapings was negative for fungal elements or cultures. The coral- red fluorescence of the plaque under a Wood’s lamp (WL) examination was characteristic of erythrasma [Figure 1B]. The patient was treated with 500 mg of oral erythromycin every 12 hours for 14 days, with progressive healing observed over three weeks. Comment Erythrasma is a localised and chronic skin infection caused by Corynebacterium minutissimum.1–3 It appears as patches that are either asymptomatic and well-defined or irregular in shape and size and red/ brown in colour.3–5 The diagnosis is usually clinical, but a WL examination can show characteristic fluor- escence due to coproporphyrin III produced by the bacteria.2,3 The WL emits ultraviolet A radiation with Figure 1A & B: A: Diffuse, brownish, well-defined, scaly plaque in the left inguinal region of a 50-year-old man. Note the ‘cigarette paper’ appearance. B: Wood’s light skin examination of the plaque showing bright coral-red fluorescence characteristic of erythrasma. interesting medical image Sultan Qaboos University Med J, August 2016, Vol. 16, Iss. 3, pp. e381–382, Epub. 19 Aug 16 Submitted 10 Jan 16 Revision Req. 1 Feb 16; Revision Recd. 1 Mar 16 Accepted 13 Mar 16 doi: 10.18295/squmj.2016.16.03.023 Coral-Red Fluorescence of Erythrasma Plaque e382 | SQU Medical Journal, August 2016, Volume 16, Issue 3 References 1. Klatte JL, van der Beek N, Kemperman PM. 100 years of Wood’s lamp revised. J Eur Acad Dermatol Venereol 2015; 29:842–7. doi: 10.1111/jdv.12860. 2. Blasco Morente G, Martínez Peinado C, Martínez García E, Tercedor Sánchez J. [Wood’s lamp in congenital erythropoietic porphyria]. An Pediatr (Barc) 2014; 81:403–4. doi: 10.1016/j. anpedi.2014.01.005. 3. Wilson BB, Wagenseller A, Noland MM. An atypical present- ation of erythrasma. J Am Acad Dermatol 2012; 67:e217–18. doi: 10.1016/j.jaad.2012.04.004. 4. Chodkiewicz HM, Cohen PR. Erythrasma: Successful treat- ment after single-dose clarithromycin. Int J Dermatol 2013; 52:516–18. doi: 10.1111/j.1365-4632.2011.05005.x. 5. Holdiness MR. Erythrasma and common bacterial skin infections. Am Fam Physician 2003; 67:254. wavelengths between 320–400 nm and is useful in the diagnosis of disorders of pigmentation, skin infections (such as erythrasma) and porphyrias.2 However, microscopic examinations (e.g. Gram staining of an epidermis scraping to reveal Gram-positive filaments and rods) and cultures on different types of media (e.g. 20% fetal bovine serum, 2% agar and 78% tissue culture medium #199) may be required in certain cases.4,5 A potassium hydroxide preparation of tissue scrapings can rule out concomitant infections, especially in patients with interdigital involvement.4 The differential diagnosis of erythrasma includes candidiasis, psoriasis and dermatophytosis.1–5 The most effective treatment is 500 mg of erythromycin twice daily for 14 days, with cure rates as high as 100%; however, other treatments with topical antibiotics and antifungals have also demonstrated good responses.1–5 http://dx.doi.org/10.1111/jdv.12860 http://dx.doi.org/10.1016/j.anpedi.2014.01.005 http://dx.doi.org/10.1016/j.anpedi.2014.01.005 http://dx.doi.org/10.1016/j.jaad.2012.04.004 http://dx.doi.org/10.1111/j.1365-4632.2011.05005.x